List of bibliographic references
Number of relevant bibliographic references: 73.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000008 (1999) |
A. Schrag [Royaume-Uni] ; L. Schelosky ; U. Scholz ; Werner Poewe [Autriche] | Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges. |
| 000015 (1999) |
R. Chen [États-Unis] ; B I Karp ; S R Goldstein ; W. Bara-Jimenez ; Z. Yaseen ; M. Hallett | Effect of muscle activity immediately after botulinum toxin injection for writer's cramp. |
| 000050 (1999) |
R. Ceravolo [Royaume-Uni] ; S. Salvetti ; P. Piccini ; C. Lucetti ; G. Gambaccini ; U. Bonuccelli | Acute and chronic effects of clozapine in essential tremor. |
| 000061 (1999) |
S A Factor [États-Unis] ; E S Molho | Transient benefit of amantadine in Parkinson's disease: the facts about the myth. |
| 000164 (1999) |
G. Ebersbach [Autriche] ; M. Stöck ; J. Müller ; G. Wenning ; J. Wissel ; Werner Poewe [Autriche] | Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration. |
| 000304 (2000) |
W. Ondo [États-Unis] ; C. Hunter ; K D Vuong ; K. Schwartz ; Joseph Jankovic [États-Unis] | Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. |
| 000337 (2000) |
I. Reuter [Royaume-Uni] ; S. Harder ; M. Engelhardt ; H. Baas | The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa. |
| 000339 (2000) |
E. Luginger [Autriche] ; G K Wenning ; S. Bösch ; Werner Poewe [Autriche] | Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease. |
| 000634 (2001) |
B. Högl ; K. Seppi ; E. Brandauer ; G. Wenning ; Werner Poewe [Autriche] | Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report. |
| 000665 (2002) |
Susan H. Fox [Royaume-Uni] ; Mark Kellett ; A Peter Moore ; Alan R. Crossman ; Jonathan M. Brotchie | Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. |
| 000862 (2002) |
| Anticholinergic therapies in the treatment of Parkinson's disease. |
| 000998 (2003) |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley ; Jim A R. Jeffs ; Ronald K B. Pearce ; Peter G. Bain | Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. |
| 000A16 (2003) |
Charles H. Adler [États-Unis] ; John N. Caviness ; Joseph G. Hentz ; Marlene Lind ; Judy Tiede | Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. |
| 000A64 (2003) |
Christine Brefel-Courbon [France] ; Karine Desboeuf ; Claire Thalamas ; Monique Galitzky ; Jean-Michel Senard ; Olivier Rascol ; Jean-Louis Montastruc | Clinical and economic analysis of spa therapy in Parkinson's disease. |
| 000A65 (2003) |
Rajesh Pahwa [États-Unis] ; Kelly E. Lyons | Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. |
| 000B91 (2003) |
Jau-Shin Lou [États-Unis] ; Greg Kearns ; Theodore Benice ; Barry Oken ; Gary Sexton ; John Nutt | Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. |
| 000C03 (2003) |
Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel ; Jörg Kazenwadel ; Thomas C. Wetter ; Wolfgang Oertel ; Roland Selzer ; Ralf Kohnen | One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome? |
| 000C23 (2003) |
Kirsten E. Zeuner [États-Unis] ; Fiona M. Molloy ; Richard O. Shoge ; Susanne R. Goldstein ; Robert Wesley ; Mark Hallett | Effect of ethanol on the central oscillator in essential tremor. |
| 000D44 (2004) |
Virgilio Gerald H. Evidente ; Cynthia Cooper ; Katrina Gwinn-Hardy | Limb cooling and focal dystonia. |
| 000E17 (2004) |
Susan Fox [Royaume-Uni] ; Montague Silverdale ; Mark Kellett ; Rhys Davies ; Malcolm Steiger ; Nicholas Fletcher ; Alan Crossman ; Jonathan Brotchie | Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease. |
| 000F26 (2004) |
Jan C M. Zijlmans [Royaume-Uni] ; Berengere Debilly ; Olivier Rascol ; Andrew J. Lees ; Franck Durif | Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Cross-Over Studies"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i \
-Sk "Cross-Over Studies" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= Mesh.i
|clé= Cross-Over Studies
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
